NCT05766449View on ClinicalTrials.gov

Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

March 1, 2027

Study Completion Date

May 1, 2027

Conditions

Chronic Hepatitis bNon-alcoholic Fatty Liver Disease

Trial Locations (1)

Unknown

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

All Listed Sponsors

lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER